Compositions and associated methods for radioisotope-binding microparticles
The present disclosure relates to polymeric materials that may be labeled with a radioisotope, to processes for producing the labeled polymeric material, and to methods of using the materials in analytical and therapeutic applications. Specifically, the disclosure relates to injectable and implantable microparticles, such as microspheres, which are associated with radioisotopes such that the microparticles are both therapeutic and detectable. The radioisotope-containing microparticles are useful for embolization and other therapeutic medical applications.
1. A method of preparing an embolic microsphere, comprising:
fabricating a microsphere comprising a polymerized monomer and a chelating agent, wherein the chelating agent comprises a compound of Formula I:
wherein n is between 1 and 18, inclusive;
Xa and Xb each are independently O, S or N; and
R is alkyl or H,
wherein the chelating agent is configured to chelate a radioisotope, wherein the monomer comprises at least one of an acrylate, acrylamide, or acrylic monomer, wherein the microsphere comprises a diameter ranging from about 1 micrometer to about 2000 micrometers, and wherein the microsphere is non-biodegradable and suitable for embolization wherein the microsphere comprises between about 1% and about 20% by weight of chelating agent.
2. The method of claim 1 , wherein the chelating agent is polymerized with the monomer.
3. The method of claim 1 , wherein the monomer is selected from at least one of the following: N-[tris(hydroxymethyl)methyl]-acrylamide or sodium acrylate.
4. The method of claim 1 , wherein the method further comprises:
associating the microsphere with a radioisotope.
5. The method of claim 4 , wherein the radioisotope is both a β- and γ-emitter.
6. The method of claim 4 , wherein the radioisotope is selected from at least one of the following: 90 Y, 32 P, 99m Tc, 111 In, 67 Ga, 166 Dy, 201 Th, 131 I, 140 La, 153 Sm, 165 Dy, 166 Ho, 169 Er, 175 Yb, 177 Lu, 186 Re, or 188 Re.
7. The method of claim 4 , wherein the radioisotope is not leached from the microsphere to an extent greater than about 3% of its original level by weight over a period of three months.
8. A method of preparing an embolic microsphere, comprising:
fabricating a microsphere comprising a polymerized monomer and a chelating agent, wherein the microsphere is non-biodegradable and wherein the chelating agent is configured to chelate a radioisotope that is a β-emitter,
wherein the monomer is selected from at least one of the following: acrylate, acrylamide, or acrylic, and
wherein the chelating agent is selected from at least one of the following: mercaptoacetyltriglycine; a mercaptoacetyltriglycine derivative; EDTA; an EDTA derivative including EGTA, BAPTA, DOTA, DTPA-monoamide, DO3A, NOTA-Bn, NODASA, and NODAGA; a crown ether; iminodiacetic acid; styrene; butyl acrylate; glycidyl methacrylate; aminocarboxylic acids such as alkylenediamine-N,N,N′,N′-tetraacetic acid-(meth)acrylamide (MAM-EDTA); acrylic acid; butyl methacrylate; bromomethyl acrylate; α-chloromethacryloyl chloride; isonicotinyl hydrazone; 2-methacryloxy-5-methyl benzophenone; pyridoxal isonicotinyl hydrazone; peptides; oligomers; amino acids; phosphorodiamidate morpholino oligomers; dimercaptosuccinic acids; pentetic acid; hydroxyethylidine diphosphonate; 4-hexadecyl-2,2,9,9-tetramethyl-4,7-diaza-1,10-decanedithiol (HDD); an ethyl cysteinate dimer/lipiodol mixture; or a bis(diethyldithiocarbamato)nitrido (DEDC) chelator wherein the microsphere comprises between about 1% and about 20% by weight of chelating agent.
9. The method of claim 8 , wherein the chelating agent comprises mercaptoacetyltriglycine or a mercaptoacetyltriglycine derivative.
10. The method of claim 9 , wherein the chelating agent comprises a compound of Formula I
wherein n is between 1 and 18, inclusive;
Xa and Xb each are independently be 0, S or N; and
R is alkyl or H.
11. The method of claim 8 , wherein the method further comprises:
associating the microsphere with a radioisotope.
12. The method of claim 11 , wherein the radioisotope is both a β- and γ-emitter.
13. The method of claim 11 , wherein the radioisotope is selected from at least one of the following: 90 Y, 32 P, 99m Tc, 111 In, 67 Ga, 166 Dy, 201 Th, 131 I, 140 Le, 153 Sm, 165 Dy, 166 Ho, 169 Er, 175 Yb, 177 Lu, 186 Re, or 188 Re.
14. A method of preparing an embolic microsphere, comprising:
fabricating a microsphere comprising a polymer and a chelating agent, wherein the polymer comprises at least one of an acrylate, acrylamide, or acrylic monomer, wherein the chelating agent comprises a compound of
wherein n is between 1 and 18, inclusive;
Xa and Xb each are independently 0, S or N; and
R is alkyl or H,
wherein the chelating agent is configured to chelate a radioisotope that is a β-emitter, and wherein the microsphere is substantially non-biodegradable and comprises a diameter ranging from about 1 micrometer to about 2000 micrometers wherein the microsphere comprises between about 1% and about 20% by weight of chelating agent.
15. The method of claim 14 , wherein fabricating the microsphere comprises:
polymerizing the chelating agent and the monomer.
16. The method of claim 14 , wherein fabricating the microsphere comprises:
linking the chelating agent to the microsphere.